Treatment of aspergillosis

JD Jenks, M Hoenigl - Journal of Fungi, 2018 - mdpi.com
Infections caused by Aspergillus spp. remain associated with high morbidity and mortality.
While mold-active antifungal prophylaxis has led to a decrease of occurrence of invasive …

Specificity Influences in (1→3)-β-d-Glucan-Supported Diagnosis of Invasive Fungal Disease

MA Finkelman - Journal of Fungi, 2020 - mdpi.com
(1→ 3)-β-glucan (BDG) testing as an adjunct in the diagnosis of invasive fungal disease
(IFD) has been in use for nearly three decades. While BDG has a very high negative …

[HTML][HTML] Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

AJ Ullmann, JM Aguado, S Arikan-Akdagli… - Clinical Microbiology …, 2018 - Elsevier
Abstract The European Society for Clinical Microbiology and Infectious Diseases, the
European Confederation of Medical Mycology and the European Respiratory Society Joint …

Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021

AP Douglas, OC Smibert, A Bajel… - Internal Medicine …, 2021 - Wiley Online Library
Invasive aspergillosis (IA) in haematology/oncology patients presents as primary infection or
breakthrough infection, which can become refractory to antifungal treatment and has a high …

Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German …

M Ruhnke, G Behre, D Buchheidt, M Christopeit… - Mycoses, 2018 - Wiley Online Library
Invasive fungal diseases (IFD) are a primary cause of morbidity and mortality in patients with
haematological malignancies. These infections are mostly life‐threatening and an early …

Diagnosis of invasive aspergillosis in hematological malignancy patients: performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and …

S Heldt, J Prattes, S Eigl, B Spiess, H Flick… - Journal of Infection, 2018 - Elsevier
Background Aspergillus spp. induce elevated levels of several cytokines. It remains
unknown whether these cytokines hold value for clinical routine and enhance diagnostic …

Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people

M Cruciani, C Mengoli, R Barnes… - Cochrane Database …, 2019 - cochranelibrary.com
Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in
immunocompromised people - Cruciani, M - 2019 | Cochrane Library Skip to Content …

Diagnosis and Treatment of Invasive Aspergillosis Caused by Non-fumigatus Aspergillus spp.

J Stemler, C Többen, C Lass-Flörl, J Steinmann… - Journal of Fungi, 2023 - mdpi.com
With increasing frequency, clinical and laboratory-based mycologists are consulted on
invasive fungal diseases caused by rare fungal species. This review aims to give an …

Whole metagenome profiles of particulates collected from the International Space Station

NA Be, A Avila-Herrera, JE Allen, N Singh… - Microbiome, 2017 - Springer
Background The built environment of the International Space Station (ISS) is a highly
specialized space in terms of both physical characteristics and habitation requirements. It is …

Galactomannan detection in broncho‐alveolar lavage fluid for invasive aspergillosis in immunocompromised patients

K de Heer, MG Gerritsen, CE Visser… - Cochrane Database …, 2019 - cochranelibrary.com
Background Invasive aspergillosis (IA) is a life‐threatening opportunistic mycosis that occurs
in some people with a compromised immune system. The serum galactomannan enzyme …